These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 18288982)
1. Endoradiotherapy with peptides - status and future development. Haberkorn U; Eisenhut M; Altmann A; Mier W Curr Med Chem; 2008; 15(3):219-34. PubMed ID: 18288982 [TBL] [Abstract][Full Text] [Related]
2. Development of molecular techniques for imaging and treatment of tumors. Haberkorn U; Markert A; Eisenhut M; Mier W; Altmann A Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):655-70. PubMed ID: 22231585 [TBL] [Abstract][Full Text] [Related]
3. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy. de Visser M; Verwijnen SM; de Jong M Cancer Biother Radiopharm; 2008 Apr; 23(2):137-57. PubMed ID: 18454684 [TBL] [Abstract][Full Text] [Related]
4. Endoradiotherapy in cancer treatment--basic concepts and future trends. Zoller F; Eisenhut M; Haberkorn U; Mier W Eur J Pharmacol; 2009 Dec; 625(1-3):55-62. PubMed ID: 19836381 [TBL] [Abstract][Full Text] [Related]
5. Radiolabeled peptides and proteins in cancer therapy. Wängler C; Buchmann I; Eisenhut M; Haberkorn U; Mier W Protein Pept Lett; 2007; 14(3):273-9. PubMed ID: 17346233 [TBL] [Abstract][Full Text] [Related]
6. Current status and perspectives in peptide receptor radiation therapy. Ansquer C; Kraeber-Bodéré F; Chatal JF Curr Pharm Des; 2009; 15(21):2453-62. PubMed ID: 19601842 [TBL] [Abstract][Full Text] [Related]
8. Experience with indium-111 and yttrium-90-labeled somatostatin analogs. Virgolini I; Traub T; Novotny C; Leimer M; Füger B; Li SR; Patri P; Pangerl T; Angelberger P; Raderer M; Burggasser G; Andreae F; Kurtaran A; Dudczak R Curr Pharm Des; 2002; 8(20):1781-807. PubMed ID: 12171531 [TBL] [Abstract][Full Text] [Related]
9. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods. Eberle AN; Mild G J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167 [TBL] [Abstract][Full Text] [Related]
10. Identification of Ligands and Translation to Clinical Applications. Haberkorn U; Mier W; Kopka K; Herold-Mende C; Altmann A; Babich J J Nucl Med; 2017 Sep; 58(Suppl 2):27S-33S. PubMed ID: 28864609 [TBL] [Abstract][Full Text] [Related]
11. Preclinical and clinical studies of peptide receptor radionuclide therapy. Pool SE; Krenning EP; Koning GA; van Eijck CH; Teunissen JJ; Kam B; Valkema R; Kwekkeboom DJ; de Jong M Semin Nucl Med; 2010 May; 40(3):209-18. PubMed ID: 20350630 [TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs. Mariani G; Erba PA; Signore A J Nucl Med; 2006 Dec; 47(12):1904-7. PubMed ID: 17138731 [No Abstract] [Full Text] [Related]
13. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals. Boerman OC; Oyen WJ; Corstens FH Semin Nucl Med; 2000 Jul; 30(3):195-208. PubMed ID: 10928383 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic applications of radiolabeled peptides in nuclear endocrinology. Behr TM; Béhé M; Becker W Q J Nucl Med; 1999 Sep; 43(3):268-80. PubMed ID: 10568142 [TBL] [Abstract][Full Text] [Related]
15. Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs. Kwekkeboom DJ; Mueller-Brand J; Paganelli G; Anthony LB; Pauwels S; Kvols LK; O'dorisio TM; Valkema R; Bodei L; Chinol M; Maecke HR; Krenning EP J Nucl Med; 2005 Jan; 46 Suppl 1():62S-6S. PubMed ID: 15653653 [TBL] [Abstract][Full Text] [Related]
16. Biotechnology techniques for the development of new tumor specific peptides. Marr A; Markert A; Altmann A; Askoxylakis V; Haberkorn U Methods; 2011 Nov; 55(3):215-22. PubMed ID: 21640826 [TBL] [Abstract][Full Text] [Related]
17. Somatostatin analogs for cancer treatment and diagnosis: an overview. Scarpignato C; Pelosini I Chemotherapy; 2001; 47 Suppl 2():1-29. PubMed ID: 11275699 [TBL] [Abstract][Full Text] [Related]
19. Peptide-based radiopharmaceuticals for targeted tumor therapy. Dong C; Liu Z; Wang F Curr Med Chem; 2014; 21(1):139-52. PubMed ID: 23992337 [TBL] [Abstract][Full Text] [Related]